收藏切换
Effect of Fuzheng Yiliu Fang combined with mFOLFOX6 on intestinal flora in patients with colon cancer
收藏切换
Jiarui HU, Shaobo QU, Xiaohua HE, Daiwei LIU, Yongxia WANG, Zhanlin LI*
World Clinical Drug | 2024, 45(4) : 385 - 390
Less
收藏切换
World Clinical Drug | 2024, 45(4): 385-390
• Article •
Effect of Fuzheng Yiliu Fang combined with mFOLFOX6 on intestinal flora in patients with colon cancer
Full
Jiarui HU, Shaobo QU, Xiaohua HE, Daiwei LIU, Yongxia WANG, Zhanlin LI*
Affiliations
  • Department of Traditional Chinese Medicine, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075061, Hebei Province, China
Published: 2024-04-10 doi: 10.13683/j.wph.2024.04.007
Outline
收藏切换
Objective

To investigate the effect of Fuzheng Yiliu Fang combined with mFOLFOX6 chemotherapy on the clinical benefit rate and intestinal flora of patients with colon cancer.

Methods

A total of 106 patients with advanced colon cancer admitted to our hospital from February 2021 to May 2023 were selected and divided into chemotherapy group (mFOLFOX6 chemotherapy) and combination group (combined with Fuzheng Yiliu Fang on the basis of chemotherapy group) according to random number table method, with 53 cases in each group. The efficacy, intestinal flora, immune indexes and incidence of adverse reactions were compared between the two groups.

Results

The clinical benefit rate of combination group (84.31%) was higher than that of chemotherapy group (64.00%, P<0.05). After treatment, the number of Bifidobacterium and Lactobacillus in combination group was higher than before treatment and higher than that in chemotherapy group (P<0.05), and the number of Escherichia coli was lower than before treatment and higher than that in chemotherapy group (P<0.05). After treatment, the levels of CD4+ and CD4+/CD8+ in combination group were higher than those in chemotherapy group, and CD8+ was lower than that in chemotherapy group (P<0.05). The incidence of gastrointestinal reaction (29.41%) and myelosuppression (13.73%) in combination group were lower than those in chemotherapy group (66.00%, 32.00%, P<0.05).

Conclusion

Fuzheng Yiliu Fang combined with mFOLFOX6 can effectively regulate intestinal flora, significantly reduce the impact of chemotherapy on immune function, significantly reduce gastrointestinal reactions, bone marrow suppression and other adverse reactions of chemotherapy in the treatment of advanced colon cancer patients, and help to improve the clinical benefit rate.

Fuzheng Yiliu Fang  /  mFOLFOX6 chemotherapy  /  colon cancer  /  clinical benefit rate  /  intestinal microbiota
胡嘉芮, 渠少博, 何晓华, 刘戴维, 王永霞, 李占林. 扶正抑瘤方联合mFOLFOX6治疗对结肠癌患者肠道菌群的影响. 世界临床药物, 2024 , 45 (4) : 385 -390 . DOI: 10.13683/j.wph.2024.04.007
Jiarui HU, Shaobo QU, Xiaohua HE, Daiwei LIU, Yongxia WANG, Zhanlin LI. Effect of Fuzheng Yiliu Fang combined with mFOLFOX6 on intestinal flora in patients with colon cancer[J]. World Clinical Drug, 2024 , 45 (4) : 385 -390 . DOI: 10.13683/j.wph.2024.04.007
Year 2024 volume 45 Issue 4
19
5
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.04.007
  • Receive Date:2023-11-23
  • Online Date:2026-11-17
  • Published:2024-04-10
Article Data
Affiliations
History
  • Received:2023-11-23
Funding
Affiliations
    Department of Traditional Chinese Medicine, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075061, Hebei Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.04.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT